Latest Advancement In Treatment Options For Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is a type of cancer that starts in the blood-forming cells of the bone marrow and then spreads to the blood. Many people suffering from this condition don’t show any symptoms for at least a few years, as the leukemia cells build up slowly. Over time, these cancerous cells can spread to other parts of the body, including the liver, spleen, and the lymph nodes.
New drugs and drug combinations
To increase the likelihood that patients live longer and have a complete remission, researchers have found new drugs and are doing their best to find a new treatment for chronic lymphocytic leukemia. Different combinations of the already developed treatments, such as targeted therapy and chemotherapy, are also being studied. There are many new drugs for CLL, including latest kinase inhibitors. Additionally, researchers are trying to combine various drugs to create one treatment that is highly effective in treating CLL.
Genetics
Another new treatment for chronic lymphocytic leukemia that is being researched is related to human genetics. Several genetic changes are being evaluated to determine the best treatment and how well the treatment would work. Some examples include measuring the immunoglobulin mutations of the CLL cells, finding different chromosomal abnormalities in the CLL cells, and finding the effects of a protein called ZAP-70 found on the surface of the CLL cells.
Palliative care
A multidisciplinary approach including specialized medical and nursing care for people suffering from life-limiting illnesses such as CLL is termed as palliative care. It cannot be termed as a new treatment for chronic lymphocytic leukemia but is certainly something that can help patients and their families going through tough times because of CLL. Clinical trials are being done globally to improve palliative care to improve the patient’s quality of life and comfort. It helps alleviate symptoms and stress related to serious illnesses.